Brief: Gracell Biotechnologies Says Will Be Required To Pay Astrazeneca Treasury Limited $33.1 Million On Termination Of Deal Under Specified Circumstances

Gracell Biotechnologies

26/12/2023 13:22

Dec 26 (Reuters) - Gracell Biotechnologies Inc  GRCL.O :
    * GRACELL BIOTECHNOLOGIES - ON TERMINATION OF DEAL UNDER
SPECIFIED
CIRCUMSTANCES, CO WILL BE REQUIRED TO PAY ASTRAZENECA TREASURY
LIMITED $33.1 MILLION
    * GRACELL BIOTECHNOLOGIES - ASTRAZENECA TREASURY LIMITED TO
PAY CO
TERMINATION FEE OF $41.1 MILLION UPON TERMINATION OF DEAL UNDER
SPECIFIED CIRCUMSTANCES

Source text for Eikon: [ID: https://www.sec.gov/Archives/edgar/data/1283699/000119312523302486/d683664dsc13da.htm
]
Further company coverage:  GRCL.O 

 ((Reuters.Briefs@thomsonreuters.com;))